These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 26824421)

  • 1. Osteopontin promotes epithelial-mesenchymal transition of hepatocellular carcinoma through regulating vimentin.
    Dong Q; Zhu X; Dai C; Zhang X; Gao X; Wei J; Sheng Y; Zheng Y; Yu J; Xie L; Qin Y; Qiao P; Zhou C; Yu X; Jia H; Ren N; Zhou H; Ye Q; Qin L
    Oncotarget; 2016 Mar; 7(11):12997-3012. PubMed ID: 26824421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteopontin regulates epithelial mesenchymal transition-associated growth of hepatocellular cancer in a mouse xenograft model.
    Bhattacharya SD; Mi Z; Kim VM; Guo H; Talbot LJ; Kuo PC
    Ann Surg; 2012 Feb; 255(2):319-25. PubMed ID: 22241292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokine ligand 20 enhances progression of hepatocellular carcinoma via epithelial-mesenchymal transition.
    Hou KZ; Fu ZQ; Gong H
    World J Gastroenterol; 2015 Jan; 21(2):475-83. PubMed ID: 25593462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
    World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOX9 is a novel cancer stem cell marker surrogated by osteopontin in human hepatocellular carcinoma.
    Kawai T; Yasuchika K; Ishii T; Miyauchi Y; Kojima H; Yamaoka R; Katayama H; Yoshitoshi EY; Ogiso S; Kita S; Yasuda K; Fukumitsu K; Komori J; Hatano E; Kawaguchi Y; Uemoto S
    Sci Rep; 2016 Jul; 6():30489. PubMed ID: 27457505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-130b promotes proliferation and EMT-induced metastasis via PTEN/p-AKT/HIF-1α signaling.
    Chang RM; Xu JF; Fang F; Yang H; Yang LY
    Tumour Biol; 2016 Aug; 37(8):10609-19. PubMed ID: 26861561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteopontin promotes a cancer stem cell-like phenotype in hepatocellular carcinoma cells via an integrin-NF-κB-HIF-1α pathway.
    Cao L; Fan X; Jing W; Liang Y; Chen R; Liu Y; Zhu M; Jia R; Wang H; Zhang X; Zhang Y; Zhou X; Zhao J; Guo Y
    Oncotarget; 2015 Mar; 6(9):6627-40. PubMed ID: 25749383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA AOC4P suppresses hepatocellular carcinoma metastasis by enhancing vimentin degradation and inhibiting epithelial-mesenchymal transition.
    Wang TH; Lin YS; Chen Y; Yeh CT; Huang YL; Hsieh TH; Shieh TM; Hsueh C; Chen TC
    Oncotarget; 2015 Sep; 6(27):23342-57. PubMed ID: 26160837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M; Zhang XY; Yu X
    Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MAP4K4 promotes epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma.
    Feng XJ; Pan Q; Wang SM; Pan YC; Wang Q; Zhang HH; Zhu MH; Zhang SH
    Tumour Biol; 2016 Aug; 37(8):11457-67. PubMed ID: 27010469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelial to mesenchymal transition is associated with shorter disease-free survival in hepatocellular carcinoma.
    Yamada S; Okumura N; Wei L; Fuchs BC; Fujii T; Sugimoto H; Nomoto S; Takeda S; Tanabe KK; Kodera Y
    Ann Surg Oncol; 2014 Nov; 21(12):3882-90. PubMed ID: 24833103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of osteopontin with peritumoral infiltrating macrophages is associated with poor prognosis of early-stage hepatocellular carcinoma after curative resection.
    Zhu W; Guo L; Zhang B; Lou L; Lin Z; Zhu X; Ren N; Dong Q; Ye Q; Qin L
    Ann Surg Oncol; 2014 Apr; 21(4):1304-13. PubMed ID: 24366422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-630 suppresses tumor metastasis through the TGF-β- miR-630-Slug signaling pathway and correlates inversely with poor prognosis in hepatocellular carcinoma.
    Chen WX; Zhang ZG; Ding ZY; Liang HF; Song J; Tan XL; Wu JJ; Li GZ; Zeng Z; Zhang BX; Chen XP
    Oncotarget; 2016 Apr; 7(16):22674-86. PubMed ID: 26993767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbonic anhydrase 2 inhibits epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma.
    Zhang C; Wang H; Chen Z; Zhuang L; Xu L; Ning Z; Zhu Z; Wang P; Meng Z
    Carcinogenesis; 2018 Apr; 39(4):562-570. PubMed ID: 29309535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of hepatitis C virus (HCV)-induced osteopontin and its role in epithelial to mesenchymal transition of hepatocytes.
    Iqbal J; McRae S; Banaudha K; Mai T; Waris G
    J Biol Chem; 2013 Dec; 288(52):36994-7009. PubMed ID: 24240095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-26a-5p suppresses tumor metastasis by regulating EMT and is associated with prognosis in HCC.
    Chang L; Li K; Guo T
    Clin Transl Oncol; 2017 Jun; 19(6):695-703. PubMed ID: 27864783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOXF2 deficiency promotes hepatocellular carcinoma metastasis by inducing mesenchymal-epithelial transition.
    Dou C; Jin X; Sun L; Zhang B; Han M; Li T
    Cancer Biomark; 2017 Jul; 19(4):447-454. PubMed ID: 28582850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus x protein induces epithelial-mesenchymal transition of hepatocellular carcinoma cells by regulating long non-coding RNA.
    Jin Y; Wu D; Yang W; Weng M; Li Y; Wang X; Zhang X; Jin X; Wang T
    Virol J; 2017 Dec; 14(1):238. PubMed ID: 29258558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.
    Wang YP; Yu GR; Lee MJ; Lee SY; Chu IS; Leem SH; Kim DG
    Hepatology; 2013 Oct; 58(4):1349-61. PubMed ID: 23696034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological significance of ZEB1 protein in patients with hepatocellular carcinoma.
    Zhou YM; Cao L; Li B; Zhang RX; Sui CJ; Yin ZF; Yang JM
    Ann Surg Oncol; 2012 May; 19(5):1700-6. PubMed ID: 21584833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.